BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 9408958)

  • 61. The prognostic significance of membrane transport-associated multidrug resistance (MDR) proteins in leukemia.
    van den Heuvel-Eibrink MM; Sonneveld P; Pieters R
    Int J Clin Pharmacol Ther; 2000 Mar; 38(3):94-110. PubMed ID: 10739113
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics.
    Wuchter C; Karawajew L; Ruppert V; Büchner T; Schoch C; Haferlach T; Ratei R; Dörken B; Ludwig WD
    Leukemia; 1999 Dec; 13(12):1943-53. PubMed ID: 10602414
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Differential expression of drug-resistance-related genes between sensitive and resistant blasts in acute myeloid leukemia.
    Eisele L; Klein-Hitpass L; Chatzimanolis N; Opalka B; Boes T; Seeber S; Moritz T; Flasshove M
    Acta Haematol; 2007; 117(1):8-15. PubMed ID: 17095854
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Multidrug resistance mediated by membrane P-glycoprotein in acute myeloid leukemia].
    Su LP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Oct; 11(5):544-8. PubMed ID: 14575557
    [TBL] [Abstract][Full Text] [Related]  

  • 65. P-glycoprotein, lung resistance-related protein and multidrug resistance associated protein in de novo acute non-lymphocytic leukaemias: biological and clinical implications.
    Michieli M; Damiani D; Ermacora A; Masolini P; Raspadori D; Visani G; Scheper RJ; Baccarani M
    Br J Haematol; 1999 Feb; 104(2):328-35. PubMed ID: 10050716
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Multi-drug resistance (MDR1) gene expression in de novo acute leukemia cells: correlations with CD surface markers and treatment outcome.
    Jiang EZ; Chang YJ; Lee JW; Lee WK; Kim JS; Sohn SK; Lee KB; Suh JS
    J Korean Med Sci; 1998 Dec; 13(6):617-22. PubMed ID: 9886170
    [TBL] [Abstract][Full Text] [Related]  

  • 67. MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemia.
    Schaich M; Soucek S; Thiede C; Ehninger G; Illmer T;
    Br J Haematol; 2005 Feb; 128(3):324-32. PubMed ID: 15667534
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of P-glycoprotein expression with in vitro drug sensitivity in fresh blast cells from acute myeloid leukaemia patients.
    Faulkner Pulsford JF; Sargent JM; Elgie AW; Williamson CJ; Taylor CG
    Br J Biomed Sci; 1995 Sep; 52(3):188-94. PubMed ID: 8527996
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Multidrug resistance. Clinical opportunities in diagnosis and circumvention.
    Chan HS; DeBoer G; Thorner PS; Haddad G; Gallie BL; Ling V
    Hematol Oncol Clin North Am; 1994 Apr; 8(2):383-410. PubMed ID: 7913705
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Expression and functional activity of P-glycoprotein in adult acute myelogenous leukemia patients.
    Nuessler V; Gullis E; Pelka-Fleischer R; del Valle F; Diem H; Beyerlein S; Zwierzina H; Wilmanns W
    Ann Hematol; 1997; 75(1-2):17-26. PubMed ID: 9322679
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia.
    de Figueiredo-Pontes LL; Pintão MC; Oliveira LC; Dalmazzo LF; Jácomo RH; Garcia AB; Falcão RP; Rego EM
    Cytometry B Clin Cytom; 2008 May; 74(3):163-8. PubMed ID: 18200595
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A sensitive multilayer immunoalkaline phosphatase method for detection of P-glycoprotein in leukemic and tumor cells in the bone marrow.
    Haddad G; Thorner PS; Bradley G; Dalton WS; Ling V; Chan HS
    Lab Invest; 1994 Oct; 71(4):595-603. PubMed ID: 7967514
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Interaction of WAVE1 and genes involved in multiple drug resistance in children with acute myeloblastic leukemia].
    Yang MH; Zhao MY; He YL; Wang MH; Wang Z; Xie M; Wu XS; Cao LZ
    Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):175-9. PubMed ID: 20426950
    [TBL] [Abstract][Full Text] [Related]  

  • 74. BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML).
    Santamaría C; Chillón MC; García-Sanz R; Pérez C; Caballero MD; Mateos MV; Ramos F; de Coca AG; Alonso JM; Giraldo P; Bernal T; Queizán JA; Rodríguez JN; Puig N; Balanzategui A; Sarasquete ME; Alcoceba M; Díaz-Mediavilla J; San Miguel J; González M
    Ann Hematol; 2010 May; 89(5):453-8. PubMed ID: 19943049
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Induction of the multidrug-transporter P-glycoprotein by 3'-azido-3'-deoxythymidine (AZT) treatment in tumor cell lines.
    Signoretti C; Romagnoli G; Turriziani O; Antonelli G; Dianzani F; Cianfriglia M
    J Exp Clin Cancer Res; 1997 Mar; 16(1):29-32. PubMed ID: 9148857
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Expression and significance of P-gp/mdr1 mRNA, MRP and LRP in non-Hodgkin's lymphoma].
    Li L; Su LP; Ma L; Zhao J; Zhu L; Zhou YA
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):199-202. PubMed ID: 19615260
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Activity of bortezomib in adult de novo and relapsed acute myeloid leukemia.
    Gil L; Styczynski J; Dytfeld D; Debski R; Kazmierczak M; Kolodziej B; Rafinska B; Kubicka M; Nowicki A; Komarnicki M; Wysocki M
    Anticancer Res; 2007; 27(6B):4021-5. PubMed ID: 18225565
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemia.
    Lee EJ; Yang J; Leavitt RD; Testa JR; Civin CI; Forrest A; Schiffer CA
    Leukemia; 1992 Nov; 6(11):1203-9. PubMed ID: 1279324
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Drug efflux transporters and multidrug resistance in acute leukemia: therapeutic impact and novel approaches to mediation.
    Xia CQ; Smith PG
    Mol Pharmacol; 2012 Dec; 82(6):1008-21. PubMed ID: 22826468
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The expression of the multidrug transporter P-170 glycoprotein in remission phase is associated with early and resistant relapse in multiple myeloma.
    Musto P; Lombardi G; Matera R; Carotenuto M
    Haematologica; 1991; 76(6):513-6. PubMed ID: 1687943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.